Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Circulatory Shock|July 1, 1992
Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shockF Squadrito, D Altavilla, M Ioculano, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1992
IRFI-016, a new radical scavenger, limits ischemic damage following coronary artery occlusion in ratsG M Campo, F Squadrito, M Ioculano, et al.
European Journal of Pharmacology|November 3, 1995
G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesisD Altavilla, F Squadrito, P Canale, et al.
British Journal of Pharmacology|December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.
British Journal of Pharmacology|June 1, 1995
Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the ratF Squadrito, D Altavilla, L Ammendolia, et al.
Journal of Lipid Mediators|August 1, 1993
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
International Journal of Microcirculation, Clinical and Experimental|March 1, 1995
Soluble E-selectin levels in acute human myocardial infarctionF Squadrito, D Altavilla, M Ioculano, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
Agents and Actions|October 1, 1994
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.
Pageof 4